Pre-operative Bowel Preparation Prior to Minimally Invasive Sacral Colpopexy

Sponsor
Halina M Zyczynski, MD (Other)
Overall Status
Completed
CT.gov ID
NCT01805310
Collaborator
(none)
95
1
2
53.9
1.8

Study Details

Study Description

Brief Summary

Prior to surgery, gynecologists and urogynecologists have routinely prescribed preoperative mechanical bowel preparations in attempts to decrease the risk of infection, while also providing easier bowel manipulation and better visualization during surgery. However, many of these proposed benefits have never been proven, and usage of bowel preparations amongst surgeons remains highly variable. In both the general surgery and gynecology literature, researchers have begun to question the need for the vigorous preparations.

Aside from surgical visualization, urogynecologists have additional concerns about how bowel preparations may impact postoperative bowel function given up to half of women with pelvic floor disorders have baseline constipation and straining is known to impact surgical recovery. Many studies have addressed various postoperative fiber and laxative preparations in attempts to improve postoperative bowel-related symptomatology, but none have specifically looked at preoperative bowel preparations.

This study aims to determine if mechanical bowel preparation prior to minimally invasive sacral colpopexy affects patients' postoperative recovery, specifically related to bowel symptomatology; operative or post-operative complications; surgeons' perceptions of surgical difficulty directly attributed to the bowel; and post-operative return of normal bowel function.

Condition or Disease Intervention/Treatment Phase
  • Other: Bowel preparation
  • Other: No bowel preparation
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
95 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Pre-operative Bowel Preparation Prior to Minimally Invasive Sacral Colpopexy
Study Start Date :
Feb 1, 2013
Actual Primary Completion Date :
Aug 1, 2017
Actual Study Completion Date :
Aug 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Other: Bowel Preparation

Women randomized to the bowel preparation arm will be instructed to consume 300cc of magnesium citrate no later than 3PM on preoperative day number one. They will also be placed on a clear liquid diet on preoperative day number one.

Other: Bowel preparation
Subjects randomized to the mechanical bowel preparation arm will be instructed to consume 300cc of magnesium citrate no later than 3PM on preoperative day number one.
Other Names:
  • Magnesium citrate
  • Other: No bowel preparation

    Subjects randomized to no bowel preparation will be instructed to continue a regular diet on preoperative day number one.

    Other: No bowel preparation
    Subjects randomized to no bowel preparation will be instructed to continue a regular diet on preoperative day number one.

    Outcome Measures

    Primary Outcome Measures

    1. PAC-SYM [1 year]

      Bowel symptomatology and bowel-related discomfort will be assessed with the Patient Assessment of Constipation Symptom Questionnaire (PAC-SYM), a 12-item questionnaire covering three domains: abdominal, rectal, and stool.

    Secondary Outcome Measures

    1. Surgeon perception of bowel preparation [1 year]

      Immediately after completing the surgical case, surgeons will complete a 13-item surgeon questionnaire assessing degree of surgical difficulty and how it relates to the bowel. Operative time and consultations will also be recorded as objective measures of surgical difficulty.

    2. Return of normal bowel function [1 year]

      A seven-day bowel diary will be obtained at baseline and in the first week after surgery. This log will include daily assessment of bowel frequency, type of bowel movement using the validated Bristol stool scale, degree of straining, and used of narcotics or laxatives.

    3. Perioperative complications [1 year]

      Complications occurring in both groups will be recorded. These include, but are not limited to infections, bowel obstructions, visceral organ injuries, and readmissions.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Female

    • Age ≥ 18 years

    • Planned laparoscopic or robotic-assisted sacral colpopexy

    Exclusion Criteria:
    • History of ulcerative colitis or Crohn's disease

    • Prior large or small bowel resection

    • Known diagnosis of gastroparesis

    • Prior pelvic radiation

    • History of abdominal or pelvic malignancy

    • Planned concurrent bowel surgery/anal sphincteroplasty/ rectovaginal fistula repair

    • Pregnancy

    • Known allergic reactions to components of the study products

    • Known renal insufficiency

    • Non-English speaking as the primary study questionnaires are all currently in English only

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Pittsburgh Medical Center Pittsburgh Pennsylvania United States 15213

    Sponsors and Collaborators

    • Halina M Zyczynski, MD

    Investigators

    • Principal Investigator: Kelly L Kantartzis, MD, University of Pittsburgh
    • Principal Investigator: Halina M Zyczynski, MD, University of Pittsburgh

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Halina M Zyczynski, MD, MD, University of Pittsburgh
    ClinicalTrials.gov Identifier:
    NCT01805310
    Other Study ID Numbers:
    • PRO12020453
    First Posted:
    Mar 6, 2013
    Last Update Posted:
    Jan 9, 2018
    Last Verified:
    Jan 1, 2018
    Keywords provided by Halina M Zyczynski, MD, MD, University of Pittsburgh
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 9, 2018